Yuyu Pharma, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seoul Korea, Republic of (1941)
Status: No NME R&D (1941)

Organization Overview

First Clinical Trial
2008
NCT01008163
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hangzhou YuYuan Bioscience Technology Co., Ltd. | Yuyu Pharma, Inc.